Literature DB >> 21436754

Survival outcomes in surgical treatment of 72 cases of squamous cell carcinoma of the temporal bone.

Fang-Lu Chi1, Feng-Ming Gu, Chun-Fu Dai, Bing Chen, Hua-Wei Li.   

Abstract

OBJECTIVE: To evaluate surgical outcomes for squamous cell carcinoma of the temporal bone. STUDY
DESIGN: Retrospective study.
SETTING: Eye and ENT Hospital.
METHODS: Seventy-two patients with squamous cell carcinoma of the temporal bone were analyzed for survival. The patients were staged according to the modified Pittsburgh staging system. Five patients with T1 cancers underwent local resection (LR), and 10 patients with T1 cancers underwent lateral temporal bone resection (LTBR). Two patients with T2 cancers underwent LR, and 1 patient with T2 cancer underwent LTBR. One patient with T3 cancer underwent LR, 8 patients with T3 cancers underwent LTBR, and 10 patients with T3 cancers underwent subtotal temporal bone resection (STBR). Ten patients with T4 cancers underwent LTBR, and 25 patients with T4 cancers underwent STBR.
RESULTS: Of all patients that underwent surgery, 18 died of their disease during the follow-up time. The 5-year survival rates of patients with T stages 1 through 4 were 100%, 67%, 21%, and 14%, respectively. There was no statistically significant difference in 5-year survival rate between T3 and T4 using the log-rank test (p > 0.05). The 5-year survival rates after LTBR and STBR for T3 were 26% and 16% (p > 0.05), respectively, and those for T4 were 17% and 11% (p > 0.05), respectively.
CONCLUSION: An en bloc resection is favored in an effort to produce negative surgical margins for squamous cell carcinoma of the temporal bone. Adjunctive radiotherapy is used for advanced lesions.

Entities:  

Mesh:

Year:  2011        PMID: 21436754     DOI: 10.1097/MAO.0b013e318210b90f

Source DB:  PubMed          Journal:  Otol Neurotol        ISSN: 1531-7129            Impact factor:   2.311


  17 in total

1.  Predictors of survival and recurrence after temporal bone resection for cancer.

Authors:  Luc G T Morris; Saral Mehra; Jatin P Shah; Mark H Bilsky; Samuel H Selesnick; Dennis H Kraus
Journal:  Head Neck       Date:  2011-09-23       Impact factor: 3.147

2.  Treatment and outcome of middle ear cancer.

Authors:  Xianhao Jia; Qin Liang; Fanglu Chi
Journal:  Eur Arch Otorhinolaryngol       Date:  2014-10       Impact factor: 2.503

3.  Primary definitive radiotherapy with or without chemotherapy for squamous cell carcinoma of the temporal bone.

Authors:  Yosuke Kitani; Akira Kubota; Madoka Furukawa; Kaname Sato; Yuko Nakayama; Tetsuo Nonaka; Nobutaka Mizoguchi
Journal:  Eur Arch Otorhinolaryngol       Date:  2015-03-31       Impact factor: 2.503

4.  Lateral temporal bone resection in advanced cutaneous squamous cell carcinoma: report of 35 patients.

Authors:  Garth F Essig; Leon Kitipornchai; Felicity Adams; Dannie Zarate; Mitesh Gandhi; Sandro Porceddu; Benedict Panizza
Journal:  J Neurol Surg B Skull Base       Date:  2012-12-12

5.  Temporal bone carcinoma: Treatment patterns and survival.

Authors:  Kristen L Seligman; Daniel Q Sun; Patrick P Ten Eyck; Nathan M Schularick; Marlan R Hansen
Journal:  Laryngoscope       Date:  2019-03-15       Impact factor: 3.325

6.  The misdiagnosis of external auditory canal carcinoma.

Authors:  Ting Zhang; ChunFu Dai; ZhengMin Wang
Journal:  Eur Arch Otorhinolaryngol       Date:  2012-08-25       Impact factor: 2.503

7.  Dramatic response of CTNNB1 and VEGFR-2 mutant temporal bone squamous cell carcinoma to bevacizumab in combination with pemetrexed.

Authors:  Lai Wei; Lizhi Wang; Ziye Liu; Meiyi Wang; Weili Lu; Dewei Zhao; Bin Yang; Xuejun Kong; Yan Ding; Zhiqiang Wang
Journal:  Oncotarget       Date:  2017-07-28

8.  Skull Base Invasion Patterns of Malignant Head and Neck Tumors: A Neurosurgical Perspective.

Authors:  Kenichiro Iwami; Masazumi Fujii; Naoki Nishio; Takashi Maruo; Yasushi Fujimoto; Keisuke Takanari; Yuzuru Kamei; Masayuki Yamada; Tetsuya Ogawa; Koji Osuka; Kiyoshi Saito
Journal:  J Neurol Surg B Skull Base       Date:  2020-01-08

9.  Prognostic models to predict overall and cause-specific survival for patients with middle ear cancer: a population-based analysis.

Authors:  Weidong Shen; Naoko Sakamoto; Limin Yang
Journal:  BMC Cancer       Date:  2014-08-01       Impact factor: 4.430

10.  Expression profiling of long noncoding RNA identifies lnc-MMP3-1 as a prognostic biomarker in external auditory canal squamous cell carcinoma.

Authors:  Hong Liu; Chunfu Dai; Qianru Wu; Hongyan Liu; Feitian Li
Journal:  Cancer Med       Date:  2017-09-29       Impact factor: 4.452

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.